DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pbrh4l/ablation) has announced the addition of the "Ablation Catheters Market in the US 2015-2019" report to their offering.
The analysts forecast the ablation catheters market in the US is expected to grow at a CAGR of 12.23% over the period 2014-2019.
The report includes the present scenario and the growth prospects of the ablation catheters market in the US for the period 2015-2019. The market can be segmented into two types: Single point ablation catheter and multi-electrode ablation catheter.
The report, Ablation Catheters Market in the US 2015-2019, has been prepared based on in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors.
Cardiac arrhythmia is one of the leading causes of premature death and is characterized by the abrupt loss of heart function. Cardiac dysfunction results in the inhibition of blood flow to the brain and other vital organs. Arrhythmia is a condition resulting in abnormal heartbeat, which occurs due to changes in electrical impulses. The electrical impulses can either be too fast or too slow, resulting in sudden cardiac arrest. According to a 2013 report by the AHA, more than 450,000 people die annually in the US because of sudden cardiac arrest.
Vendors are focusing on developing innovative ablation catheter devices through application of advanced technology. They also aim to reduce the manufacturing costs to provide efficient and useful tools to deliver tailored treatments to patients. For instance, St. Jude Medical received FDA approval for Flexibility Ablation Catheters, an irrigated ablation catheter with a flexible tip, in the US in January 2015.
According to the report, catheter ablation is a Minimally Invasive (MI) procedure that helps remove faulty electrical pathways in the heart. Atrial Fibrillation (AF) is one of the leading causes of stroke in the US and affects over 5 million people. About 240,000 catheter ablation procedures were performed in the US in 2014. Therefore, rise in incidence of AF has led to rise in demand for ablation catheter procedures.
Further, the report states that shortage of skilled professionals is a major challenge restricting market growth.
Key Vendors
- Biosense Webster (A J&J company)
- Boston Scientific
- Medtronic
- St. Jude Medical
Other Prominent Vendors
- Advanced Cardiac Therapeutics
- Angiodynamics
- APT MEDICAL
- Atricure
- Biotronik
- CardioFocus
- Covidien
- DVx
- Edwards Lifesciences
- Estech
- Hansen Medical
- Imricor Medical Systems
- Japan Lifeline
- LEPU MEDICAL
- Melys AFSM
- MicroPort
- Osypka
- PLC Medical Systems
- Spectranetics
- Stereotaxis
For more information visit http://www.researchandmarkets.com/research/pbrh4l/ablation
